Mr.President D.Trump will lose the election in this November 2020 or not ? If yes how about Dow index will plunge or up ? Please experts here who could explain ? If Trump lose how about KLCI and glove conuters ? Could further uptrend ? or Plunge ... ? Para hadirin dan tuan tuan dan puan puan, keputusan piliharaya utk Amerika Syarikat pada bulan 11 ni jika En. D.Trump terkandas apa akan terjadi kepada KLCI dan harga saham sarung tangan di Malaysia ? siapa pakar di sini boleh tolong lah explain.
Minister Clarifies Pharmaniaga, Duopharma Not Appointed For Covid-19 Vaccine ‘Fill-Finish’
KUALA LUMPUR, July 28 — Minister Khairy Jamaluddin clarified in Parliament today that the government has not selected local pharmaceutical companies — Pharmaniaga Bhd and Duopharma Biotech Bhd — to undertake fill-finish processing for any Covid-19 vaccine.
The minister of science, technology and innovation told the Dewan Rakyat that the two government-linked companies were simply identified as pharmaceutical corporations with the capacity to conduct fill-finish processing, which is a process where the active agent of the pharmaceutical product is formulated or mixed into its final form (like liquid or powder), and filling and sealing it within final containers (like prefilled syringes).
“The National Science Council, in a meeting on July 14, has discussed the public-private approach for the fill-and-finish stage. The decision in selecting the companies for fill-and-finish is not simply confined to Duopharma and Pharmaniaga,” Khairy told Parit MP Nizar Zakaria.
“They are among the choices of companies now with the capacity to conduct fill-and-finish.”
The Umno lawmaker had asked Khairy in Parliament if it was true that the government has decided to appoint Pharmaniaga and Duopharma for fill-finish processing of a Covid-19 vaccine in Malaysia, the criteria for selection of the two companies, and why they were not selected based on open tender.
“However, the selection of the companies must be done and be based on their capacity for local manufacturing of pharmaceutical products according to good manufacturing practice (GMP), as per the standards of the Pharmaceutical Inspection Cooperation Scheme (PIC/S),” Khairy said.
(CNN) A third US company has released study results showing its coronavirus vaccine is safe and elicits an immune response.
Novavax, Inc. released Phase 1 data Tuesday from 131 volunteers showing that after two doses of the vaccine, participants developed neutralizing antibodies at levels more than four times higher on average than the antibodies developed by people who had recovered from Covid-19. Neutralizing antibodies fight off the virus that causes Covid-19.
Business is growing in terms of revenue and PBT. Hardly find such results during Covid 19 period. Not affected by MCO at all. Growing instead. Too good.
Good Quarter Result, business was not affected as it was categorized as essential services during MCO. Increase of revenue and income year to year. Strong cashflow and low/zero debts.This share definitely worth more than the current price. Buying in....
MCO period slow it down. Next few QR will substantially bring down the PE especially after it Commision its factory during may 2020. Investors have not price in this yet. Second thing, it has potential to be vaccine candidate. Third, its R
Increased the amount of dividend from 1.1 cents a year to 1.43 cents in total this year. At least 30% of net profit is distributed according to its dividend policy.
proposed transfer of the listing of and quotation for the entire issued share capital of Nova from the ACE Market to the Main Market of Bursa Malaysia Securities Berhad ("Bursa Securities").
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
shortinvestor77
5,487 posts
Posted by shortinvestor77 > 2020-07-27 22:33 | Report Abuse
Agree. No limit.